Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement

Ashraf Haddad; Michel Suter; Jan Willem Greve; Scott Shikora; Gerhard Prager; Barham Abu Dayyeh; Manoel Galvao; Karen Grothe; Miguel Herrera; Lilian Kow; Carel Le Roux; Mary O'Kane; Chetan Parmar; Luiz Gustavo Quadros; Almino Ramos; Josep Vidal; Ricardo Cohen

doi:10.1007/s11695-024-07489-7

Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement

Ashraf Haddad^*, Michel Suter, Jan Willem Greve, Scott Shikora, Gerhard Prager, Barham Abu Dayyeh, Manoel Galvao, Karen Grothe, Miguel Herrera, Lilian Kow, Carel Le Roux, Mary O'Kane, Chetan Parmar, Luiz Gustavo Quadros, Almino Ramos, Josep Vidal, Ricardo Cohen

^*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Abstract

Obesity is a chronic disease that may require multiple interventions and escalation of therapy throughout the years. Until recently, no universal definition existed for recurrent weight gain and insufficient weight loss. Standardization of reporting is key so outcomes can be compared and data can be pooled. The recent IFSO consensus provided standard terminology and definitions that will likely resolve this in the future, and publishers will need to enforce for authors to use these definitions. This current IFSO position statement provides guidance for the management of recurrent weight gain after bariatric surgery.

Original language	English
Article number	3944–3962
Pages (from-to)	3944-3962
Number of pages	19
Journal	Obesity Surgery
Volume	34
Issue number	11
DOIs	https://doi.org/10.1007/s11695-024-07489-7
Publication status	Published - Nov 2024

Keywords

Metabolic bariatric surgery
Recurrent weight gain
Suboptimal clinical response gastric bypass
Roux-en-Y gastric bypass
One anastomosis gastric bypass
Revision
Revisional bariatric surgery
ROUX-EN-Y
DUODENO-ILEAL BYPASS
TRANSORAL OUTLET REDUCTION
ANASTOMOSIS GASTRIC BYPASS
ARGON PLASMA COAGULATION
SLEEVE GASTRECTOMY
BILIOPANCREATIC DIVERSION
GASTROJEJUNAL ANASTOMOSIS
ALCOHOL-USE
REGAIN

Access to Document

10.1007/s11695-024-07489-7

Cite this

Haddad, A., Suter, M., Greve, J. W., Shikora, S., Prager, G., Abu Dayyeh, B., Galvao, M., Grothe, K., Herrera, M., Kow, L., Le Roux, C., O'Kane, M., Parmar, C., Quadros, L. G., Ramos, A., Vidal, J., & Cohen, R. (2024). Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement. Obesity Surgery, 34(11), 3944-3962. Article 3944–3962. https://doi.org/10.1007/s11695-024-07489-7

@article{a52722b017b640db9235a9be720b28b1,

title = "Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement",

abstract = "Obesity is a chronic disease that may require multiple interventions and escalation of therapy throughout the years. Until recently, no universal definition existed for recurrent weight gain and insufficient weight loss. Standardization of reporting is key so outcomes can be compared and data can be pooled. The recent IFSO consensus provided standard terminology and definitions that will likely resolve this in the future, and publishers will need to enforce for authors to use these definitions. This current IFSO position statement provides guidance for the management of recurrent weight gain after bariatric surgery.",

keywords = "Metabolic bariatric surgery, Recurrent weight gain, Suboptimal clinical response gastric bypass, Roux-en-Y gastric bypass, One anastomosis gastric bypass, Revision, Revisional bariatric surgery, ROUX-EN-Y, DUODENO-ILEAL BYPASS, TRANSORAL OUTLET REDUCTION, ANASTOMOSIS GASTRIC BYPASS, ARGON PLASMA COAGULATION, SLEEVE GASTRECTOMY, BILIOPANCREATIC DIVERSION, GASTROJEJUNAL ANASTOMOSIS, ALCOHOL-USE, REGAIN",

author = "Ashraf Haddad and Michel Suter and Greve, {Jan Willem} and Scott Shikora and Gerhard Prager and {Abu Dayyeh}, Barham and Manoel Galvao and Karen Grothe and Miguel Herrera and Lilian Kow and {Le Roux}, Carel and Mary O'Kane and Chetan Parmar and Quadros, {Luiz Gustavo} and Almino Ramos and Josep Vidal and Ricardo Cohen",

year = "2024",

month = nov,

doi = "10.1007/s11695-024-07489-7",

language = "English",

volume = "34",

pages = "3944--3962",

journal = "Obesity Surgery",

issn = "0960-8923",

publisher = "Springer, Cham",

number = "11",

}

Haddad, A, Suter, M, Greve, JW, Shikora, S, Prager, G, Abu Dayyeh, B, Galvao, M, Grothe, K, Herrera, M, Kow, L, Le Roux, C, O'Kane, M, Parmar, C, Quadros, LG, Ramos, A, Vidal, J & Cohen, R 2024, 'Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement', Obesity Surgery, vol. 34, no. 11, 3944–3962, pp. 3944-3962. https://doi.org/10.1007/s11695-024-07489-7

TY - JOUR

T1 - Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery

T2 - An IFSO Position Statement

AU - Haddad, Ashraf

AU - Suter, Michel

AU - Greve, Jan Willem

AU - Shikora, Scott

AU - Prager, Gerhard

AU - Abu Dayyeh, Barham

AU - Galvao, Manoel

AU - Grothe, Karen

AU - Herrera, Miguel

AU - Kow, Lilian

AU - Le Roux, Carel

AU - O'Kane, Mary

AU - Parmar, Chetan

AU - Quadros, Luiz Gustavo

AU - Ramos, Almino

AU - Vidal, Josep

AU - Cohen, Ricardo

PY - 2024/11

Y1 - 2024/11

N2 - Obesity is a chronic disease that may require multiple interventions and escalation of therapy throughout the years. Until recently, no universal definition existed for recurrent weight gain and insufficient weight loss. Standardization of reporting is key so outcomes can be compared and data can be pooled. The recent IFSO consensus provided standard terminology and definitions that will likely resolve this in the future, and publishers will need to enforce for authors to use these definitions. This current IFSO position statement provides guidance for the management of recurrent weight gain after bariatric surgery.

AB - Obesity is a chronic disease that may require multiple interventions and escalation of therapy throughout the years. Until recently, no universal definition existed for recurrent weight gain and insufficient weight loss. Standardization of reporting is key so outcomes can be compared and data can be pooled. The recent IFSO consensus provided standard terminology and definitions that will likely resolve this in the future, and publishers will need to enforce for authors to use these definitions. This current IFSO position statement provides guidance for the management of recurrent weight gain after bariatric surgery.

KW - Metabolic bariatric surgery

KW - Recurrent weight gain

KW - Suboptimal clinical response gastric bypass

KW - Roux-en-Y gastric bypass

KW - One anastomosis gastric bypass

KW - Revision

KW - Revisional bariatric surgery

KW - ROUX-EN-Y

KW - DUODENO-ILEAL BYPASS

KW - TRANSORAL OUTLET REDUCTION

KW - ANASTOMOSIS GASTRIC BYPASS

KW - ARGON PLASMA COAGULATION

KW - SLEEVE GASTRECTOMY

KW - BILIOPANCREATIC DIVERSION

KW - GASTROJEJUNAL ANASTOMOSIS

KW - ALCOHOL-USE

KW - REGAIN

U2 - 10.1007/s11695-024-07489-7

DO - 10.1007/s11695-024-07489-7

M3 - (Systematic) Review article

SN - 0960-8923

VL - 34

SP - 3944

EP - 3962

JO - Obesity Surgery

JF - Obesity Surgery

IS - 11

M1 - 3944–3962

ER -

Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement

Abstract

Keywords

Access to Document

Fingerprint

Cite this